S ystolic and diastolic blood pressure (SBP and DBP) are complex phenotypes, with known environmental and genetic risk factors.
a lesser extent DBP, in adolescence and early adulthood is associated with subsequent adult risk of coronary heart disease and stroke. 28, 29 Understanding the risk factors, including genetic variation, that are associated with SBP and DBP through childhood and into adolescence may therefore inform an improved understanding of the life course pathogenesis of adult hypertension and cardiovascular disease. GWAS of BP in children to date have been limited to investigations of crosssectional BP in individual cohorts, 30 often in non-European populations. 31, 32 The principal aim of the current study was to identify age-specific genetic associations with SBP and DBP across childhood and adolescence. The secondary aim was to compare results from this GWAS to published results from adult GWAS of BP.
Methods

EAGLE Consortium: BP Working Group
Seven pregnancy/birth or childhood cohorts of European ancestry from the Early Genetics and Lifecourse Epidemiology (EAGLE) Consortium BP working group with completed genome-wide genotyping and measures of SBP and DBP on participants between the ages of 4 and 20 years contributed to this study.
Each study was conducted with appropriate institutional ethics approval, and written informed consent was obtained from participants or their main caregivers. Each study conducted their own GWAS analyses, and results were then pooled using meta-analysis. The methodology for recruitment of participants and measurement of BP for each cohort are described in the Data Supplement.
Only those participants who had at least one BP measurement at, or before, 20 years of age were included in analyses. With the exception of the Brisbane Longitudinal Twin Study (BLTS), all analyses were restricted to children from singleton pregnancies, the first born (with relevant genotype and phenotype data) from cohorts that included siblings, or a randomly selected child from those that included twins. BLTS, which included all twins and siblings, took into account both zygosity and relatedness using the statistical package Merlin 33 during their GWAS.
ICBP
We used GWAS data from studies contributing to the International Consortium of Blood Pressure (ICBP) on adults who were recruited for classical or genetic epidemiological purposes from general population samples 17 to compare with associations identified in EAGLE.
Genotyping and Imputation
Single nucleotide polymorphisms (SNPs) were genotyped on one of the following platforms: Affymetrix, Illumina, or Perlegen. Predefined marker filters were applied before imputation (Hardy-Weinberg equilibrium >10 -6 , MAF >0.01, SNP call rate >95%). Each study imputed SNPs by combining their study's genotyped SNPs with HapMap Phase II CEU SNPs samples, preferably using release 22 of HapMap, build 36 . Imputation results are summarized as an allele dosage defined as the expected number of copies of the minor allele at that SNP (a fractional value between 0.0 and 2.0) for each genotype. Further details are provided in Data Supplement and Table 1 .
Statistical Analysis
Cross-Sectional GWAS
Cross-sectional associations were performed for SBP and DBP in 3 age epochs over childhood/adolescence. These epochs were chosen before any analyses and were based on previous evidence of the ages in European populations that girls go through mencarche, boy's voices break, and both sexes have a growth spurt and in part pragmatically, relating to available data in the participating studies. These epochs were the following: prepuberty (4 to ≤7 years), puberty (8 to ≤12 years), and postpuberty (13 to ≤20 years; Table 1 and Figure  I in the Data Supplement).
Genetic analyses assumed an additive model for SNP-based main effects. All analyses were adjusted for age, height, and weight, consistent with analyses used in GWAS of BP in adults (adjusted for body mass index). 14, 18, 20, 24, 34 The Z-score was calculated per individual as the difference between an individual's BP measure and the average BP measure for that given age epoch and sex for each cohort. This was then divided by the standard deviation of the BP measure across the particular cohorts' age, epoch, and sex. Those Z-scores were then regressed against each SNP (additive) adjusting for age, sex, and height of the individual. Participants could contribute to >1 epoch but only one measurement time point contributed to each epoch. The median measurement time was selected in the event that a cohort had repeatedly measured data within a single epoch.
Meta-Analyses
Separate genome-wide meta-analyses were run for SBP and DBP for each epoch using the inverse-variance weighting method in MetaAnalysis (software for GWAS) (www.sph.umich.edu/csg/abecasis/ metal). 38 Before meta-analysis, rare variants were excluded (MAF>0.01; Table I in the Data Supplement). Double genomic control correction was applied (once during the study-specific analyses [before the meta-analysis] and repeated on the statistics resulting from the meta-analysis). Heterogeneity between results from individual studies was assessed using I 2 and a Q-statistic. Further filtering based on N-effectives >70% was also used. QQ-plots for the meta-analysis of each BP outcome across each epoch and data set are presented in Figure II in the Data Supplement. A threshold of P≤5×10 −8 was used to define genome-wide levels of significance. An association of an SNP cluster was defined as ≥2 nearby variants each reaching a threshold of P≤5×10 −3 . This more liberal statistical significance level (P≤5×10 −3 ) was used to ensure the inclusion of variants that could potentially have been identified in larger samples of children.
Exploring Functionality
We used the Encyclopedia of DNA Elements 35 to investigate the functionality (transcriptional active region, H3K27Ac active regulatory 
Comparing Findings Across Epochs and in Adults
Any variants identified as associated with SBP or DBP at P≤5×10 −3 in any age epoch was examined in (1) the other 2 epochs in our study; (2) in adult participants from the ICBP, and (3) in SNPs identified as associated with adult CHD using the results from Coronary Artery Disease Genome-Wide Replication and Meta-Analysis (CARDIoGRAMplusC4D), 36 a consortium designed to identify novel susceptibility loci for coronary artery disease and myocardial infarction. 37 We also examined whether variants associated with adult BP in ICBP at P≤5 x 10 −3 for association with BP in any of the 3 epochs in our study.
Meta-analyses were conducted in Meta-Analysis (software for GWAS). The statistical software package R version 2.12.1 39 was used to produce all Manhattan Plots. Regional association plots were produced using LocusZoom.
40
Results
Seven cohorts contributed to meta-analyses, a total of 10 090 individuals for the prepubertal epoch, 8423 individuals for the pubertal epoch, and 5176 individuals for the postpubertal epoch (Table 1) . Manhattan plots for SBP and DBP by epoch are presented in Figure III in the Data Supplement. Regional association plots for the most significant SNP (by outcome and epoch, as listed in Table 2 ) are shown in Figure  IV ; Tables 2 and 3 ; Table 2 ). No SNPs reached genome-wide levels of significance for SBP in the postpubertal analyses.
Clusters of variants in several genes were associated with SBP at P≤5×10 −3 (Table 3 , Figure 1 , and Figure V in the Data Supplement): ITGA11 (prepuberty), ANLN and OR51V1 (puberty), and C1GALT1 and UGP2 (postpuberty). A cluster of SNPs was also identified surrounding SNP rs1563894 (ITGA11; prepuberty), highlighted above as showing genomewide levels of significance with prepubertal SBP. We illustrate this significant SNP cluster in more depth ( Figure 2 ).
Two SNPs were associated with the largest increases in SBP across these epochs: SNP rs3735398 (ANLN) during the pubertal epoch (β=0.116SD, 95% CI, 0.073, 0.159; P=1.28×10 −7 ; Table 3 and Figure VIII in the Data Supplement) and a cluster surrounding SNP rs3901287 (LOXL2; β=0.108SD, 95% CI, 0.059, 0.157; P=1.24×10 −5 ; Table 3 and Figure IX in the Data Supplement) was associated with postpubertal SBP.
Look-Up of Functionality of Childhood SBP Results
Several SNPs were found to be located either directly in or in close proximity to functionally active regions. For SNPs associated with SBP, rs1563894 was located on an active H3K27Ac, DNase hypersensitivity, transcription factor ChIP, and CpG methylation site ( Figure 3 and Figure 
Comparisons Across Epochs and With Adult Outcomes No SNPs reached associations of P≤5×10
−3 in all 3 epochs. Variants in chromosome 2 (rs13025174, rs13032473 [TMEM247], and rs10186089 [FSHR]) were associated with elevated SBP during prepubertal and pubertal epochs (Table 4) . Several SNPs in HORMAD2, HORMAD2-AS1, and MTMR3 were associated with SBP during the pubertal and postpubertal epochs (Table 4 and Table XIII in the Data Supplement).
None of the SNPs found to be associated (P≤5×10 −3 ) with childhood SBP were associated with adult SBP in the ICBP (Table 3) . However, several loci previously found to be associated with adult SBP in ICBP were also associated with SBP in at least one epoch of childhood in EAGLE children (Table 5) : (1) B3GNTL1 and KLHL1 (prepuberty); (2) DOK6, NKAIN2, ARGHGEF10, and MECOM (puberty) and (2) FGD5 and CSMD2 (postpuberty). One SNP that was associated with SBP in the pubertal epoch showed some possible association with CHD in adults ( ) for childhood DBP ( Table 2) . Clusters of variants in 7 loci were associated with childhood DBP (P≤5×10 −3 ; Table 3 ) and were investigated further using LocusZoom. 40 Regional associations for all of these associations are presented in Figure VI ) where all SNPs had an MAF>0.10 and all cohorts contributed to each SNP analyses (postpubertal) and at least 4 cohorts contributed to GWAS findings for the prepubertal and pubertal epochs. Beta values are in terms of Z-scores, the number of standard deviations away from the mean. Table 4 ). Variants in POT1 and CNTNAP4 were associated with consistently reducing DBP during the pubertal and postpubertal epochs (Table 4 and Table XIV in the Data  Supplement) .
None of the SNPs found to be at least associated (P≤5×10 −3 ) with childhood DBP were associated with adult BP in the ICBP (Table 4) . A number of loci previously found to be associated with adult DBP in ICBP were also associated with DBP in at least one epoch of childhood in EAGLE children (Table 5) : USP4 and GRK5 (all pubertal).
We also investigated SNPs from Tables 2 and 3 in  CARDIoGRAMplusC4D 36 and found 2 significant hits for rs12365302 (P=0.008) and rs16875222 (P=0.037; Table VII in the Data Supplement).
Additional Analyses
As a sensitivity analyses, we repeated the GWAS analyses separately in females and males and found similar directions and magnitudes of associations, though given the smaller sample sizes within these 2 subgroups were not as well powered to report on the sex-stratified associations (Tables VIII-XII in the Data Supplement). ).
Discussion
To our knowledge, this is the first GWAS to examine genetic associations with BP cross-sectionally across childhood and adolescence. This builds on our previous work in which we found that an allelic score summing the established adult GWAS hits for SBP was associated with SBP at mean age 6 years but not with age-related change in SBP between age 6 and 17. 41, 42 In the current study, we have identified 2 novel SNPs: one associated with SBP measured prepubertally and one with SBP measured during puberty. We did not find any SNPs reaching genome-wide significance with DBP or with either SBP-or DBP-measured postpuberty, but when we reduced our statistical significance threshold to P≤5×10 −3 , there were several additional variants in gene clusters relating to SBP or DBP across the 3 epochs. At this more liberal P value threshold, we found some evidence of overlap in novel SNPs across childhood/adolescent age epochs within our study and some overlap with those that have been found by previous GWAS to be associated with adult BP.
ITGA11 was genome-wide associated with SBP during the prepubertal epoch and has been shown to be associated with hypertrophic cardiomyopathy 43 and coronary artery disease. 44 An SNP in close proximity to the SMARCA and VLDLR genes (rs872256) was genome-wide associated with SBP during the pubertal epoch. SMARCA is a member of the SWI/SNF family of proteins and is highly similar to the brahma protein, where it has been hypothesized that cardiac hypertrophy and the fetal gene expression program are associated with distinguishable binding of brahma and SMARCA4 on genes. 45 From animal studies, brahma gene expression is found to be restricted to mesodermal tissues involved in early vasculogenesis and heart morphogenesis. 46 VLDLR has been shown to be associated with obesity from both animal studies [47] [48] [49] and human GWAS. 50 Recently, a pathway analyses based on results from a GWAS has identified plausible biological links between VLDR with vascular endothelial growth factor, which is known to affect angiogenesis and atherosclerosis. 51 Even with a reduced P value threshold of P≤5×10 −3 , these 2 genome-wide novel variants did not overlap with variants at this threshold in any other age group.
Some of the variants that we identified as associated with SBP or DBP in any of the different age epochs were in gene clusters that also had some evidence of potentially relevant functionality. FSHR which was associated with SBP in prepubertal and puberty has been shown to influence SBP vascular responses in hypertensive rats with hyperhomocysteinemia 52 and is known to be involved in the regulation of systemic arterial BP (GeneCards). POT1 which was associated with lower DBP in pubertal and postpubertal children is an important molecular marker for biological aging. 53 MTMR3 which was associated with lower SBP in puberty and postpuberty has been hypothesized to be a mediator for miR-4513, which is significantly associated with BP and related metabolic outcomes, such as cholesterol. 54 The fact that we have found more variants associated with SBP than with DBP may reflect differences in changes in SBP and DBP across childhood and adolescence. SBP increases across childhood to a peak at around age 15/16 years and thereafter levels off, whereas DBP seems to increase monotonically across childhood into late adolescence/early twenties. 26, 27 This is the first GWAS of BP in children at different ages, and we have maximized the sample size by collaborating across several studies with relevant data. We limited analyses Table 3 . Plots shown on left represent systolic blood pressure, plots shown on right represent diastolic blood pressure. Rows represent prepubertal (A), pubertal (B), and postpubertal (C). For regional association, plots for all significant SNP clusters presented in Table 4 to Europeans only to minimize population stratification and followed-up hits by looking up for functionality and for overlap with SNPs from GWAS in adults.
We used age groups to define epochs during which BP was measured as prepubertal, pubertal, and postpubertal. We acknowledge that some participants will have been incorrectly categorized by this method. However, it was not possible to use Tanner scores for all participants, and to have used those data would have compromised our sample size. Furthermore, assessment of pubertal stages using self-(or parental) assessment of Tanner scales, which were the methods used in most cohorts in EAGLE, is also prone to misclassification. 55 Misclassification because of using age is likely to be random, whereas Tanner scores could be systematic in relation to characteristics, such as body mass, that are related to BP.
Our sample size was too small to definitely test for sex differences, but consistent with findings from adult GWAS 17, 20, [55] [56] [57] ; there did not seem to be notable differences between females and males. In many of our analyses, we used a P value threshold that was larger than conventional genome-wide thresholds. This decision was made a priori and was intended to ensure that we did not miss potentially important associations and overlaps (between epochs and with adult GWAS findings) given the relatively modest sample size. However, we acknowledge that these findings should be treated with caution until they are replicated.
Conclusions
To conclude, we have identified 2 novel loci related to SBP in childhood (one at prepuberty and one during puberty), but none related to SBP postpuberty or in any age epoch for DBP in childhood, at genome-wide significance. The 2 novel SBP SNPs were specific to those epochs and did not relate to SBP in other epochs even with a higher P value threshold of P≤5×10 −3 . With this more liberal P value, we identified more variants related to SBP and 2 variants related to DPB measured during puberty. Most of these were specific to the particular epoch in which they were found, though for a small number, we did find overlap with adjacent epochs and also some overlap with published adult variants. Thus, our results provide some support for age-specific associations, as well as for associations that might be present across most ages. The observed genetic associations with no previous history of association with adult BP may be true novel associations, but require further investigation and replication. 
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